FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/07/043860 [Registered on: 08/07/2022] Trial Registered Prospectively
Last Modified On: 04/09/2025
Post Graduate Thesis  No 
Type of Trial  PMS 
Type of Study   Medical Device
Other (Specify) [Eye drops]  
Study Design  Other 
Public Title of Study   the study is to evaluate safety and performance of Preservative Free Eye Preparations - Preservative Free Eye Drops with Chamomile and Euphrasia extract  
Scientific Title of Study   A post market clinical follows up prospective study to evaluate safety and performance of Preservative Free Eye Preparations (Preservative Free Eye Drops with Chamomile and Euphrasia extract).  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrChethan S Sadanand 
Designation  MBBS, MS (OPHTHALMIC-SURGEON) 
Affiliation  Vivekananda Eye Hospital,Bengaluru,Karnataka 
Address  1st Floor, Room no.4, Vivekananda Eye Hospital, 2951, Esturi Towers, complex, Krishna Rajendra Rd, Siddanna Layout, Banashankari Stage II, Banashankari, Bengaluru, Karnataka 560070

Bangalore
KARNATAKA
560070
India 
Phone  9600122287  
Fax    
Email  chethan.sadanand@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrChethan S Sadanand 
Designation  MBBS, MS (OPHTHALMIC-SURGEON) 
Affiliation  Vivekananda Eye Hospital,Bengaluru,Karnataka 
Address  1st Floor, Room no.4, Vivekananda Eye Hospital, 2951, Esturi Towers, complex, Krishna Rajendra Rd, Siddanna Layout, Banashankari Stage II, Banashankari, Bengaluru, Karnataka 560070


KARNATAKA
560070
India 
Phone  9600122287  
Fax    
Email  chethan.sadanand@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrChethan S Sadanand 
Designation  MBBS, MS (OPHTHALMIC-SURGEON) 
Affiliation  Vivekananda Eye Hospital,Bengaluru,Karnataka 
Address  1st Floor, Room no.4, Vivekananda Eye Hospital, 2951, Esturi Towers, complex, Krishna Rajendra Rd, Siddanna Layout, Banashankari Stage II, Banashankari, Bengaluru, Karnataka 560070


KARNATAKA
560070
India 
Phone  9600122287  
Fax    
Email  chethan.sadanand@gmail.com  
 
Source of Monetary or Material Support  
Stericon Pharma Private Limited 
 
Primary Sponsor  
Name  Stericon Pharma Private Limited 
Address  STERICON PHARMA PRIVATE LIMITED. Plot No. 9R, Sub layout of Plot No 9, 1st Phase, Bommasandra Industrial Area, Bangalore - 560 099  
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrChethan S Sadanand  Vivekananda Eye Hospital, Bengaluru, Karnataka  1st Floor, Room no.4, Vivekananda Eye Hospital, 2951, Esturi Towers, complex, Krishna Rajendra Rd, Siddanna Layout, Banashankari Stage II, Banashankari, Bengaluru, Karnataka 560070
Bangalore
KARNATAKA 
9600122287

chethan.sadanand@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
ACE Independent Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H28||Cataract in diseases classified elsewhere,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Not Applicable  Not Applicable 
Intervention  SODIUM CHLORIDE 0.5% EYE DROPS (CHAMMOMILE EXTRACT plus EUPHRASIA EXTRACT)(PRESERVATIVE FREE)  Eye drops soothes and gives comfort to the eyes. Preservative Free Eye Drops with Chamomile and Euphrasia extract can be used to protect the eye from irritations/ discomfort due to continuous use of computer/TV/exposed pollution/dry environment, use of contact lenses. It is recommended to use one or two drops into the eye (or eyes). Many people find it is sufficient to use the drops three or four times a day, but it can be used as often as needed. If the drops have been prescribed then follow the directions given by the doctor. To apply the eye drop with herbal extract: •Instill one or two drops into each eye when required, or use as directed by your eye care practitioner. •Blink several times. •Replace the cap tightly after use. Duration of intervention is 90 days.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  At the time of screening and usage of the product all subjects must meet the following criteria for inclusion into the study and the subjects will receive the prescribed eye drops from the PI/CO-PI by a medical practitioner. The inclusion criteria for the subjects for this study are as follows:

-Subjects who experience irritation , Itchiness, discomfort of eyes due to the continuous use of computer/TV/exposed pollution/dry environment
-Subjects wearing contact lenses who experience dryness, Itchiness, discomfort of eyes due to the continuous use of computer/TV/exposed pollution/dry environment
 
 
ExclusionCriteria 
Details  The below Subjects are excluded from the study:
-Subjects who are not willing to participate in the study
-Anyone with known allergic reaction to Preservative Free Eye Drops with Chamomile and Euphrasia extract
-Subjects with existing eye infection
-Subjects undergone recent (6 weeks) cataract surgery who are on other eye medications
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The primary objective is to confirm clinical safety and performance of the
product Sodium Chloride 0.5% eye drops with Borate and Citrate buffer (eye
drop with herbal extract) by performing a set of eye examinations. 
1st Visit - After 8 days of using the product
2nd Visit - After one month of using the product
3rd Visit - After two months of using the product
4th Visit - After three months of using the product 
 
Secondary Outcome  
Outcome  TimePoints 
The secondary objective is to assess any emerging undesirable events along with monitoring of desired events, contraindications, residual risk, emerging risk under normal usage of the eye drops with herbal extract for prolonged period to ensure acceptability of benefit risk ratio of the eye drop with herbal extract, which will be recorded in CRF during every follow up visit based on the subject rating. The study will be focused on identifying possible systematic misuse or off-label use of the device.  1st Visit - After 8 days of using the product
2nd Visit - After one month of using the product
3rd Visit - After two months of using the product
4th Visit - After three months of using the product 
 
Target Sample Size   Total Sample Size="144"
Sample Size from India="144" 
Final Enrollment numbers achieved (Total)= "144"
Final Enrollment numbers achieved (India)="144" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   15/07/2022 
Date of Study Completion (India) 24/04/2023 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   No 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
A post market clinical follows up prospective study to evaluate safety and performance of Preservative Free Eye Preparations {Preservative Free Eye Drops with Herbal Extract/Sodium Chloride 0.5% Eye Drops with Borate and Citrate Buffer } (Chamomile and Euphrasia extract).

Preservative Free Eye Drops with Chamomile and Euphrasia herbal extract are used to relieve eye discomfort and soreness due to environmental factors Sodium chloride is an Electrolyte added to maintain osmolarity as high osmolarity products pull water from epithelial cells. Disodium edetate is a cationic chelating agent that binds free metals and enhances antimicrobial activity of disinfectants.  Chamomile extract used to treat eye inflammation and infection and reported for its antibacterial, anti-inflammatory, astringent properties. Cooled chamomile infusion can be used for soothe, tired, irritated eyes.  Euphrasia has antimicrobial effect. Helps treating the eyes. Euphrasia is used in eye baths and eye drops, for watery, reddened and irritated eyes, for swollen eyelids, for sticky eyes in the morning and against tired, overstrained eyes.

Boric acid to create a stable balance that resists changes in the solution’s pH. Citrate Buffer (Sodium Citrate & Citric Acid) is the most physiologic of all the common buffers, as it’s a natural buffer occurring in tears.

Preservative Free Eye Drops with Chamomile and Euphrasia  extract can be used to protect the eye from irritations/ discomfort due to continuous use of computer/TV/exposed pollution/dry environment, use of contact lenses.

 There will be 4 follow up visits expected after using the product:

 1st Visit - After 8 days of using the product

  2nd Visit - After one month of using the product

 3rd Visit - After two months of using the product

                  4th Visit - After three months of using the product 

IIntended purpose

Persons who experience irritation, Itchiness, discomfort of eyes due to the continuous use of computer/TV/exposed pollution/dry environment use the eye drop with herbal extract to soothe the eyes.

IIntended users

Persons who experience irritation/itchiness/discomfort of eyes due to the continuous use of computer/TV/ exposed pollution /dry environment.

This study will be a prospective, multi-centric, non-randomized study. The subjects visiting the study centers with the complaints such as eye irritation, Itchiness, discomfort of eyes due to the continuous use of computer/TV/exposed pollution/dry environment will be screened at Day 0 and if they meet the inclusion and exclusion criteria, then they will be selected for the study. A total of 144 subjects will be recruited for this study for the Preservative Free Eye Drops with Chamomile and Euphrasia extract.

Results-
Results-
Sodium Chloride Eye Drops (0.5%) (Chamomile plus Euphrasia) with Citrate Buffer (Preservative Free)A PMCF study was conducted in 72 subjects (30 male, 42 female) at Nalam Homoeo Clinic, Tamil Nadu, with ages ranging from below 20 to above 60 years. Four subjects discontinued (due to mild irritation, continuous adverse reaction, or unwillingness to continue). One subject was a contact lens wearer. Target patients included individuals with ocular dryness, redness, itching, irritation, and discomfort caused by screen exposure, pollution, or dry environments. 

Clinical safety was confirmed, with no major complications or device-related events reported. IOP remained stable with no significant gender-related variation (p>0.05), though age showed a significant effect on IOP. Similarly, visual acuity (UNDVA, BCDVA) remained stable, with no significant gender effect but a significant age-related variation (better performance in smaller and equal 40 years). Corneal staining remained normal throughout. Schirmer’s test demonstrated improved eye moisture, with statistically significant reduction in dryness requiring at least one month of use. Contact lens compatibility was confirmed, with no changes in base curve, power, or diameter. 

Mild burning/irritation was reported in 11 subjects (Day 8), 20 subjects (Day 30), 20 subjects (Day 60), and 21 subjects (Day 90). Complaint investigation and root cause analysis confirmed batch compliance; possible causes included individual hypersensitivity to ingredients or non-compliance with IFU. Events were non-serious, with one dropout due to discomfort. 

Clinical benefits included improved comfort, relief from soreness, moisturized eyes, and refreshed visual experience lasting 5–8 hours. Overall satisfaction was rated “good” (average score 3) by both PI and subjects. The benefit–risk ratio was favorable, with benefits outweighing mild non-serious adverse events, requiring no RMF update. 
Sodium Chloride Eye Drops (0.5%) (Chamomile plus Euphrasia) with Borate Buffer (Preservative Free) 

A parallel PMCF study was conducted in 72 subjects (33 male, 39 female) at Nalam Homoeo Clinic, Tamil Nadu. The study population included mainly adults aged 20–40 years, with three subjects under 20 and eight above 40. One subject was a contact lens wearer. Target patients had ocular dryness, itching, burning, redness, and discomfort. 

Clinical safety was established with no complications or adverse events. IOP and visual acuity values remained stable with no significant gender or age-related effects (p>0.05). Corneal staining showed no changes during follow-up. Schirmer’s test confirmed improved eye hydration, demonstrating statistically significant reduction in dryness after one month of continuous use. Contact lens compatibility was confirmed, with no changes in lens parameters. 

No side effects or adverse events were observed during the 90-day follow-up, confirming strong tolerability of the borate-buffered formulation.  
Clinical benefits included eye comfort, relief from soreness, and improved visual performance, with effect lasting 5–8 hours. Both PI and subjects rated overall satisfaction as “good” (average score 3), with improved daily quality of life reported. The benefit–risk ratio was strongly favorable, with no residual risks identified, and no RMF update required.
 
Close